Completion of Three Dose Series of HPV, Improvement in Vaccine Intervals Between HPV Doses
Conditions
Keywords
Human Papillomavirus
Brief summary
The human papillomavirus (HPV) vaccine is routinely recommended for both adolescent girls and boys starting at age 11, although it can be offered as young as 9 years of age. This is a 3-dose series and many adolescents do not complete it after getting the first dose. This study will study how effective it will be to send reminders to parents to schedule an appointment when their child is due for the next dose of HPV. Parents can chose whether they would like a phone call or text message reminder. This study will determine if the reminders work, and if one method is better than another (phone message vs. text message).
Interventions
OTHERTelephone reminder
One week prior to when a child is due for either their 2nd or 3rd HPV vaccine, their parent will receive a telephone reminder to call to make an appointment to receive their next dose. A total of 3 reminders will be sent.
One week prior to when a child is due for either their 2nd or 3rd HPV vaccine, their parent will receive a text message reminder to call to make an appointment to receive their next dose. A total of 3 reminders will be sent.
Sponsors
Agency for Healthcare Research and Quality (AHRQ)
University of Rochester
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
10 Years to 21 Years
Healthy volunteers
Yes
Inclusion criteria
* Parents of adolescents aged 10 - 17 who have had at least 1 dose of HPV * Patients aged 18 - 21 who have had at least 1 dose of HPV
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HPV completion rate | One Year | Post intervention HPV vaccination rates will be summarized by intervention group with frequencies and proportions, and will be compared between groups using chi square or Fisher's exact test as appropriate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| HPV Dosing Intervals | One Year | Dosing intervals will be summarized by group with mean, median, standard deviation and will be compared between groups using a two sample t-test. |
Countries
United States
Outcome results
None listed